People Who are Pregnant or Breastfeeding Cannot Have Testosterone
Individuals who are pregnant or breastfeeding are advised against testosterone therapy as part of gender affirming care due to potential risks to both the individual and the developing fetus or breastfeeding infant. Testosterone, a key component of masculinizing hormone therapy, can cross the placental barrier during pregnancy or transfer to the infant through breast milk during lactation. Exposure to testosterone during pregnancy may lead to virilization of female fetuses, resulting in potential masculinization of external genitalia or other developmental abnormalities. Similarly, testosterone exposure through breastfeeding may pose risks to the infant’s health and development. Therefore, individuals who are pregnant or breastfeeding must stop testosterone therapy until after pregnancy and breastfeeding are completed.
For more information, please follow this link:
Related Articles
People Who Have Prostate Cancer Cannot Have Testosterone
Individuals with prostate cancer are typically advised against testosterone therapy as part of gender affirming care due to potential risks associated with hormone-sensitive tumors. Testosterone, a primary component of masculinizing hormone therapy, ...Testosterone and Erythrocytosis
Erythrocytosis refers to thickening of the blood due to increased red blood cell production. The thickness of the blood is measured with a blood test for haematocrit, which is an estimated percentage by volume of red blood cells in the blood. The ...Unwanted Effects of Testosterone
The table below lists the known side effects, but some of these effects may actually be the desired therapeutic effects in certain medical contexts. It’s important to understand that people can have varying responses to medications, and what one ...Reference Ranges for Oestrogen and Testosterone
Why do we check oestrogen and testosterone levels? For people who are receiving oestrogen or testosterone for their gender affirming medical treatment, regular blood tests for oestrogen and testosterone levels are recommended. This is to ensure that ...Cyproterone and Young People: An Alternative in the Absence of GnRHa Puberty Blockers
Cyproterone acetate (CPA) is a medication often used in gender-affirming care and to manage conditions related to excess androgens. Typically, CPA isn't licensed for use in young people under a certain age due to the lack of information specific to ...